search.noResults

search.searching

saml.title
dataCollection.invalidEmail
note.createNoteMessage

search.noResults

search.searching

orderForm.title

orderForm.productCode
orderForm.description
orderForm.quantity
orderForm.itemPrice
orderForm.price
orderForm.totalPrice
orderForm.deliveryDetails.billingAddress
orderForm.deliveryDetails.deliveryAddress
orderForm.noItems
IN PARTNERSHIP required? • How will the comparator be used?


Countries participating in the trial: • Which countries are participating in the trial?


• Which documents are required for import and export?


• How much of the comparator product can the local market supply and at what price?


Comparator evaluation: • What is the delivery time frame for the duration of the study?


• Is there a generic form of the comparator product available?


• Who is the manufacturer and where is the product manufactured?


• Are there shortages or expiration concerns associated with the product?


Market versus manufacturer comparator sourcing strategies


Each clinical trial has its own unique complexities. It’s vital to consider multiple


options in order to choose the most efficient and cost-effective route to source comparators. There are two strategies to consider when sourcing a comparator: market versus manufacturer sourcing. Market sourcing means approaching a wholesaler in order to source the comparator product, while manufacturer sourcing means approaching the innovator company for its comparator product. Which strategy we use can be affected by: • Documentation: certificate of analysis (CoA) is available for some products and markets, but can be more difficult for rare or expensive medication. Extensive documentation can only be feasibly obtained from the manufacturer.


• Expiry: when sourcing from a manufacturer, they can often offer longer expiration dates than when sourcing products on the open market.


• Batches: large quantities of rare medication can be in multiple batches, which can complicate the packaging and labelling process.


18 | Outsourcing in Clinical Trials Handbook


Page 1  |  Page 2  |  Page 3  |  Page 4  |  Page 5  |  Page 6  |  Page 7  |  Page 8  |  Page 9  |  Page 10  |  Page 11  |  Page 12  |  Page 13  |  Page 14  |  Page 15  |  Page 16  |  Page 17  |  Page 18  |  Page 19  |  Page 20  |  Page 21  |  Page 22  |  Page 23  |  Page 24  |  Page 25  |  Page 26  |  Page 27  |  Page 28  |  Page 29  |  Page 30  |  Page 31  |  Page 32  |  Page 33  |  Page 34  |  Page 35  |  Page 36  |  Page 37  |  Page 38  |  Page 39  |  Page 40  |  Page 41  |  Page 42  |  Page 43  |  Page 44  |  Page 45  |  Page 46  |  Page 47  |  Page 48  |  Page 49  |  Page 50  |  Page 51  |  Page 52  |  Page 53  |  Page 54  |  Page 55  |  Page 56  |  Page 57  |  Page 58  |  Page 59  |  Page 60  |  Page 61  |  Page 62  |  Page 63  |  Page 64  |  Page 65  |  Page 66  |  Page 67  |  Page 68  |  Page 69  |  Page 70  |  Page 71  |  Page 72  |  Page 73  |  Page 74  |  Page 75  |  Page 76  |  Page 77  |  Page 78  |  Page 79  |  Page 80  |  Page 81  |  Page 82  |  Page 83  |  Page 84  |  Page 85  |  Page 86  |  Page 87  |  Page 88  |  Page 89  |  Page 90  |  Page 91  |  Page 92  |  Page 93  |  Page 94  |  Page 95  |  Page 96  |  Page 97  |  Page 98  |  Page 99  |  Page 100